Bio-Rad Laboratories | BIO - Nettoeinkommen

Aktienkurs
278.01
Täglich Wechseln
0.51 0.18%
Monatlich
3.01%
Jährlich
13.27%
Q2 Prognose
271.56




Nettoeinkommen Veränderung Datum
Abbott USD 1.78B 132M 2025-12
Agilent USD 305M 129M 2025-12
Becton, Dickinson and Co. USD 382M 111M 2025-12
Bio Techne USD 38.01M 176K 2025-12
Bio-Rad Laboratories USD -341.9M 659.7M 2025-09
Bruker USD 26M 88.4M 2025-12
Charles River Laboratories USD -276.56M 330.98M 2025-12
Danaher USD 1.2B 289M 2025-12
General Electric Aerospace USD 2.54B 384M 2025-12
Hologic USD 179.1M 8.2M 2025-12
Illumina USD 334M 184M 2025-12
IQVIA Holdings USD 514M 183M 2025-12
Laboratory Of America USD 164.7M 96.4M 2025-12
Merck USD 2.96B 2.82B 2025-12
Mettler Toledo International USD 285.76M 68.27M 2025-12
Myriad Genetics USD -7.9M 19.5M 2025-12
OraSure Technologies USD -19.29M 5.57M 2025-12
Pacific Biosciences Of California USD -40.37M 2.37M 2025-12
Quest Diagnostics USD 245M 0 2025-12
Repligen USD 13.29M 1.62M 2025-12
Revvity USD 98.36M 51.71M 2025-12
Roche Holding CHF 5.47B 1.76B 2025-12
Siemens EUR 2.03B 411M 2025-12
Standard Biotools USD 19.28M 53.97M 2025-12
Thermo Fisher Scientific USD 1.96B 348M 2025-12
Tosoh JPY 17.25B 16.4B 2025-12
Waters USD 225.21M 76.29M 2025-12